These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients. Miller JA, Butler T, Beveridge RA, Kales AN, Binder RA, Smith LJ, Ueno WM, Milkovich G, Goldwater S, Marion A. Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941 [Abstract] [Full Text] [Related]
15. [Clinical study of imipenem/cilastatin sodium in the perinatal period]. Yamamoto T, Yasuda J, Kanao M, Okada H. Jpn J Antibiot; 1988 Nov; 41(11):1792-6. PubMed ID: 3210310 [Abstract] [Full Text] [Related]
16. Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study. Schmitt DV, Leitner E, Welte T, Lode H. Infection; 2006 Jun; 34(3):127-34. PubMed ID: 16804655 [Abstract] [Full Text] [Related]